| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358377 Schweinfurthin analogues |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358274 Methods for treating or preventing cancer using Benzopyranone Compounds |
| 04/15/2008 | US7358269 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2240107C Novel diphenylarsines |
| 04/10/2008 | WO2008042639A1 Compounds and compositions as protein kinase inhibitors |
| 04/10/2008 | WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 04/10/2008 | WO2008040649A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/10/2008 | WO2008040445A1 Novel crystalline modification of 4- (n-methyl-2-chloro-5-pyridylmethylamino) -2,5-dihydrofuran-2-one |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
| 04/10/2008 | WO2008016596A3 Pseudobase benzo [c] phenanthridines with improved efficacy, stability, and safety |
| 04/10/2008 | WO2007144652A3 Parp inhibitors |
| 04/10/2008 | WO2007143597A3 Organic compounds |
| 04/10/2008 | WO2007120824A3 Processes for the synthesis of azetidinone |
| 04/10/2008 | WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/10/2008 | WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/10/2008 | US20080086003 1-[4-amino-3,5-dibromo-N-[[4-(2,3,4,5-tetrahydro-2(1H)-oxo-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]-D-phenylalanyl]-4-(1-piperidinyl)-piperidine-p-toluenesulphonate or other inorganic organic salts; calcitonin gene related peptide-antagonist; useful for treating headache and migraine |
| 04/10/2008 | US20080085923 Thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer; use with other drugs such as aspirin, clodipogrel, prasugrel, cangrelor, Fragmin; himbacine derivatives |
| 04/10/2008 | US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | CA2663856A1 Jak-2 modulators and methods of use |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 04/09/2008 | EP1828125B1 Arylpiperazine derivatives and their use as ligangs selective of the dopamine d3 receptor |
| 04/09/2008 | EP1727793B1 Substituted azetidine compounds as cyclooxygenase-1 - cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1461320B1 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 04/09/2008 | CN101160308A Methods of treating cancer and related methods |
| 04/09/2008 | CN101160306A 苯并咪唑化合物 Benzimidazole compounds |
| 04/09/2008 | CN101160301A Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 04/09/2008 | CN101160287A 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
| 04/09/2008 | CN101157688A 6-benzyloxy indole-2-formate furfuralcohol ester derivative and preparation method and usage thereof |
| 04/09/2008 | CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 04/09/2008 | CN100379724C Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
| 04/09/2008 | CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/08/2008 | US7355340 Electron transportation; hole blocking properties |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7355053 1-phenylpyrrolidine-2-one-3-carboxamides |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7355049 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 04/08/2008 | US7355046 Chronic obstructive pulmonary dusease; asthma |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7354946 Biarylurea derivatives |
| 04/08/2008 | US7354944 protein kinase B inhibitors; abnormal cell growth, cancer, inflammation, and metabolic disordersp; 3-(3-Fluoro-phenyl)-N-[5-(3-methyl-1H-indazol-5-yl)-[1,3,4]thiadiazol-2-yl]-propane-1,2-diamine |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/08/2008 | CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008038711A1 Oxepin derivative |
| 04/03/2008 | WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | WO2008037789A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 04/03/2008 | WO2008037626A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | WO2008018639A3 Glycine transporter inhibitor |
| 04/03/2008 | WO2008012234A3 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 04/03/2008 | WO2008008776A3 Hepatitis c virus inhibitors |
| 04/03/2008 | WO2008005955A9 Synthesis of heterocyclic compounds |
| 04/03/2008 | WO2007145834A3 Benzamide derivatives and uses related thereto |
| 04/03/2008 | WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 04/03/2008 | WO2007135131A9 Substituted pyrazinone derivatives for use as a medicine |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/03/2008 | US20080081907 5-HT5A serotonin receptor activity; such as (5-Methyl-furan-2-ylmethyl)-(5-phenoxymethyl-quinolin-2-yl)-amine; anxiety, depression, sleep disorders, schizophrenia |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | DE102006046161A1 New crystalline modified 4-((6-chloro-pyridin-3-ylmethyl)-methyl-amin o)-5H-furan-2-one exhibiting reflex positions using copper potassium-alpha-radiation, useful e.g. to combat pest and harmful insects |
| 04/03/2008 | CA2664345A1 Oxepin derivative |
| 04/03/2008 | CA2664342A1 New chemical inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | CA2664031A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/02/2008 | EP1905829A2 Templated molecules and methods for using such molecules |
| 04/02/2008 | EP1905770A1 A process for the preparation of phenyltetrazole compounds |
| 04/02/2008 | EP1905769A1 Heterocycle-substituted benzimidazole derivative |
| 04/02/2008 | EP1904487A2 Indole derivatives for the treatment of tuberculosis |
| 04/02/2008 | EP1904479A2 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 04/02/2008 | EP1904473A1 Benzoheterocyclylethylcarboxamide derivatives |
| 04/02/2008 | EP1904465A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |